Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness Stays Homeward Bound With $1.18 Billion Matria Buy

This article was originally published in The Gray Sheet

Executive Summary

Inverness Medical Innovations will continue to expand beyond its rapid point-of-care diagnostics business and into the health management services sector through its $1.18 billion acquisition of Matria Healthcare, announced Jan. 28

You may also be interested in...



Zimmer Stock Gains On Ortho Procedure Volume; S&N Also Up – Index

Orthopedic implant maker Zimmer's stock is benefiting in part from a recent boost in reconstructive implant procedure volumes and investor optimism for 2008-09

Zimmer Stock Gains On Ortho Procedure Volume; S&N Also Up – Index

Orthopedic implant maker Zimmer's stock is benefiting in part from a recent boost in reconstructive implant procedure volumes and investor optimism for 2008-09

CMS Plans To Expand Coverage For Home Anticoagulation Monitoring

CMS is proposing to expand coverage for home anticoagulation management, which could be a boon to diagnostics products made by Thoratec, Inverness Medical Innovations and Roche

UsernamePublicRestriction

Register

LL1134211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel